Evidence map›Paper›PMID 40191116›Full record

ArticleFrontiers in psychiatry2025

A case report of pregabalin misuse leading to drug dependence.

Yaan Luo, Xiafeng Zhou, Ao Xiang, Yaqi Zeng, Jing Luo, Bojie Zhou, Nana Guo, Xuhui Zhou

Abstract readCase Reports
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yaan LuoDepartment of Addiction Medicine, Hunan Institute of Mental Health, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Xiafeng ZhouDepartment of Addiction Medicine, Hunan Institute of Mental Health, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Ao XiangDepartment of Addiction Medicine, Hunan Institute of Mental Health, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Yaqi ZengDepartment of Addiction Medicine, Hunan Institute of Mental Health, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Jing LuoDepartment of Addiction Medicine, Hunan Institute of Mental Health, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Bojie ZhouDepartment of Addiction Medicine, Hunan Institute of Mental Health, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Nana GuoDepartment of Addiction Medicine, Hunan Institute of Mental Health, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Xuhui ZhouDepartment of Addiction Medicine, Hunan Institute of Mental Health, Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province), Changsha, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregabalin misuse and dependence have become emerging concerns in recent years, particularly in regions where traditional drug-related crimes have been curbed, prompting users to seek alternative substances. Although pregabalin is primarily used for treating conditions such as epilepsy, neuropathic pain, and generalized anxiety disorder, its sedative and euphoric effects make it prone to misuse. This case report presents a 20-year-old male who developed pregabalin dependence after using the drug intermittently at escalating doses over a year. He experienced withdrawal symptoms including palpitations, tremors, irritability, insomnia, and auditory hallucinations upon cessation of the drug, which were alleviated by resuming pregabalin use. Upon admission, he was diagnosed with pregabalin dependence, hyperuricemia, and thyroid nodules. The patient underwent a comprehensive treatment plan involving benzodiazepines, antidepressants, and antipsychotics, leading to substantial improvement in mood, anxiety, psychotic symptoms, and withdrawal symptoms. This case highlights the growing issue of pregabalin misuse, the associated withdrawal symptoms, and the importance of early intervention and systematic treatment strategies. It emphasizes the need for stricter prescription controls, patient education on the risks of misuse, and multidisciplinary approaches to the treatment of pregabalin dependence. Further research is necessary to better understand the mechanisms behind pregabalin misuse and to develop improved prevention and treatment protocols.

Indexed as

case reportdrug dependencedrug misusepregabalinwithdrawal symptoms

Identifiers

PMID40191116
PMCPMC11969338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.